← Back to Clinical Trials
Recruiting NCT07249996

NCT07249996 Respiratory Infections in Young Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07249996
Status Recruiting
Phase
Sponsor Eduardo Lopez -Medina
Condition Respiratory Tract Infections (RTI)
Study Type OBSERVATIONAL
Enrollment 1,088 participants
Start Date 2024-05-02
Primary Completion 2031-05-02

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 29 Days
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,088 participants in total. It began in 2024-05-02 with a primary completion date of 2031-05-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to learn about the causes, severity, and long-term effects of respiratory tract infections (RTIs) in young children from birth to five years of age in Colombia and Panamá. The main questions it aims to answer are: How often do respiratory infections occur in children under two years old, and which viruses or bacteria cause them? Why do some children develop more severe infections than others? Do early infections or vaccinations change how the immune system responds to future illnesses? How do viruses and bacteria interact in the respiratory tract to influence disease severity and long-term respiratory health? Researchers will follow newborns from birth until age five to understand how respiratory infections develop and affect children's health over time. Participants will not receive any experimental treatment. Families who join the study will: Be contacted twice a week through a phone app or phone calls to check for symptoms of respiratory infection. Attend in-person visits if their child becomes ill and every six months for routine follow-up. Provide nasal and blood samples during illness episodes so researchers can identify the viruses or bacteria causing infection and study how the immune system responds. This study began in May 2024 and is being conducted in Cali, Colombia, and Panamá City, Panamá. The research team plans to continue to include participants and continue active follow-up until the children reach five years of age. The information collected will help scientists and health professionals understand how different pathogens cause respiratory infections, what factors increase the risk of severe illness, and how early infections may influence long-term lung health. The study's findings will support future efforts to prevent and treat respiratory diseases in young children.

Eligibility Criteria

Inclusion Criteria: * Newborns younger than 29 days of life, with or without pre-existing conditions * Infants whose parent(s) or guardian(s) are available for telephone contact for the duration of the study, and do not intend to relocate outside of the study area, to ensure adherence to RTI and in-person visits. * Infants whose parent(s) or guardian(s) provide informed consent to participate in the study. * Infants whose parent(s) or guardian(s) are willing to authorize data and specimen collection, storage and analysis. Exclusion Criteria: * Infants born to a pregnant mother under 14 years of age (under Colombian law, pregnancies occurring in individuals younger than 14 years of age are legally presumed to result from sexual abuse).

Contact & Investigator

Central Contact

Eduardo Lopez-Medina, MD, MSc

✉ eduardo.lopez@ceiponline.org

📞 +57 315 0467762

Principal Investigator

Eduardo Lopez-Medina, MD, MSc

PRINCIPAL INVESTIGATOR

Centro de Estudios en Infectologia Pediatrica, CEIP

Frequently Asked Questions

Who can join the NCT07249996 clinical trial?

This trial is open to participants of all sexes, up to 29 Days, studying Respiratory Tract Infections (RTI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07249996 currently recruiting?

Yes, NCT07249996 is actively recruiting participants. Contact the research team at eduardo.lopez@ceiponline.org for enrollment information.

Where is the NCT07249996 trial being conducted?

This trial is being conducted at Cali, Colombia, Panama City, Panama.

Who is sponsoring the NCT07249996 clinical trial?

NCT07249996 is sponsored by Eduardo Lopez -Medina. The principal investigator is Eduardo Lopez-Medina, MD, MSc at Centro de Estudios en Infectologia Pediatrica, CEIP. The trial plans to enroll 1,088 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology